| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Teehan Brendan | Chief Commercial Officer | C/O PACIRA BIOSCIENCES, INC., 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE | /s/ Kristen Williams, Attorney-in-Fact | 03 Feb 2026 | 0001891900 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PCRX | Common Stock | Tax liability | $106,438 | -5,182 | -9.5% | $20.54 | 49,220 | 30 Jan 2026 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award. |